VRTX · ISSUER CIK 875320
VERTEX PHARMACEUTICALS INC / MA
Between Aug 1, 2026 and Oct 29, 2026, 4 VERTEX PHARMACEUTICALS INC / MA insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 22, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 202616:10 | Oct 20, 2026 | VRTX | Director | A · Grant | $503.47 | +795 | 795 | New | $400K | ||
| Sep 10, 202616:31 | Sep 8, 2026 | VRTX | EVP, CP and NPPO | A · Grant | — | +8,682 | 8,682 | New | — | ||
| Sep 1, 202616:39 | Aug 28, 2026 | VRTX | SVP & Chief Accounting Officer | A · Grant | — | +5,000 | 11,624 | +75% | — | ||
| Aug 31, 202616:20 | Aug 27, 2026 | VRTX | Director | G · Gift | — | −6,000 | 39,000 | -13% | — |